🧬 Voyager Therapeutics (VYGR) – Bullish Outlook
Current Price: $3.38 (pre-market)
Upside Potential: Over 300% based on analyst targets (~$15)
✅ Why VYGR Looks Promising:
Deep undervaluation: VYGR trades at a significant discount to its biotech peers despite a strong pipeline in CNS and gene therapy.
Strong institutional & insider support: Nearly half the shares are held by insiders and long-term funds—confidence in future success.
Upcoming catalysts: Clinical trial updates expected later in 2025 could spark massive upside if results are favorable.
Technical base forming: The stock has shown resilience bouncing off ~$2.50 and is now building support above $3.30, signaling accumulation.
**
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
